--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "CoroCompass CV Risk Prevention" developer_entity: "KENNETH SCOTT GUBER" bundle_id: "com.kennethguber.CoroCompass" app_store_id: "6756392894" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: true market_region: "US" platforms: "iOS" app_last_updated: "2026-03-27" report_date: "2026-09-25" last_verified: "2026-09-25T00:00:00.000Z" report_version: "1.4" total_reviews: 0 confidence: "low" confidence_score: 0.05 data_age_days: 5 momentum_velocity: "maintenance" intelligence_version: 2 tags: ["medical", "free", "mobile app", "app review", "app analysis", "cardiology", "clinicians", "healthcare"] canonical_url: "https://marlvel.ai/apps/corocompass-cv-risk-prevention" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # CoroCompass CV Risk Prevention Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free > **TL;DR:** CoroCompass CV Risk Prevention is a medical app by KENNETH SCOTT GUBER, available on iOS. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** CoroCompass CV Risk Prevention is a medical app by KENNETH SCOTT GUBER. ## Quick Facts | Fact | Value | | :--- | :--- | | **Category** | Medical | | **Developer** | KENNETH SCOTT GUBER | | **Pricing** | Free | | **Platforms** | iOS | | **Confidence** | Low (0.05/1.0) | | **Data Age** | 5d | ## Metadata & Market Performance - **Publisher:** KENNETH SCOTT GUBER - **Category:** Medical - **Target Audience:** Cardiology clinicians and healthcare providers requiring rapid, guideline-based risk assessment tools for primary prevention. - **Platforms:** iOS - **Version Reviewed:** 1.4 - **Report Date:** 2026-09-25 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.05/1.0) - **App Store ID (iOS):** 6756392894 - **Bundle ID:** com.kennethguber.CoroCompass - **Data Window:** Analysis based on signals collected up to 2026-09-25 ## Executive Snapshot **What it is:** CoroCompass is a clinical decision support tool for cardiologists, providing guideline-based risk assessment and lipid management calculators on iOS. **Why users hire it:** Clinicians need to perform rapid, guideline-aligned risk stratification during patient visits without the latency or privacy risks of cloud-based calculators. ## App DNA (Features & Intent) - **[Standard] ASCVD Risk Stratification:** Calculates 10-year cardiovascular risk using integrated guideline-based risk enhancers. * *User Intent:* Users need clear guidance to understand and adopt the product quickly. - **[Differentiator] CAC Scoring Visualization:** Maps Agatston scores and patient demographics to MESA percentiles and risk categories. - **[Differentiator] Clinical Decision Support:** Generates text-based summaries with statin and aspirin therapy recommendations based on ACC/AHA guidelines. * *User Intent:* Users need clear guidance to understand and adopt the product quickly. - **[Differentiator] Offline-First Calculation:** Performs all clinical calculations locally on the device without requiring an internet connection. * *User Intent:* Users want uninterrupted access without internet dependency. ## Market Position {#market-position} CoroCompass operates as a specialized medical utility, currently ranking #41 in its specific medical sub-category. The lack of a monetization layer suggests a brand-building or professional-utility focus rather than immediate revenue capture. ## Monetization Strategy - **Model:** Free - **Tiers:** Free - **Analysis:** CoroCompass is currently offered as a free utility with no visible monetization or subscription gates. ## SWOT Analysis {#swot} **Core Strengths:** - Offline-first processing removes connectivity dependency - Local-only calculation ensures patient data privacy **Growth Levers:** - EHR-compatible export formats could drive institutional adoption - Expansion into secondary prevention risk calculators ## What's New - **Latest (v1.4, 6 months ago):** Integrated 2026 ACC/AHA/Multisociety Dyslipidemia Guidelines, including updated risk assessment tools and statin therapy recommendations. ## App Momentum (Maintenance) {#momentum} - Integrated 2026 ACC/AHA/Multisociety guidelines. - Ships ~2 releases per year. > **Cadence:** 1 total versions · 1 majors in last 6 months · 181 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} CoroCompass CV Risk Prevention is a medical app that is completely free. > **Bottom Line:** CoroCompass provides high-utility, offline-first clinical support that builds professional trust through privacy-first design. Strengthening EHR integration would unlock institutional adoption, moving the app from a personal reference tool to a standard clinical workflow component. **Best for:** Cardiology clinicians and healthcare providers requiring rapid, guideline-based risk assessment tools for primary prevention. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Ship EHR-compatible clinical summary exports because clinicians report manual data entry as a primary workflow friction → increase professional utility ### Outlook: Stable The medical utility market is shifting toward privacy-compliant, offline-capable tools that integrate into existing clinical workflows. CoroCompass is well-positioned to serve this segment, provided it maintains a rigorous update cycle to match evolving ACC/AHA guidelines. - ⚪ The 6-month update cadence indicates a maintenance-mode posture, which is sufficient for stable guidelines but risky if clinical standards shift rapidly. - 🟢 Local-only processing addresses the growing clinician demand for data privacy, creating a defensible niche against cloud-heavy medical reference rivals. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Total Reviews | 0 | | Confidence | Low | | Pricing Model | Free | | Platforms | iOS | | Key Features | 4 analyzed | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **CoroCompass CV Risk Prevention** (this app) | N/A/5 | N/A | KENNETH SCOTT GUBER | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** KENNETH SCOTT GUBER ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/corocompass-cv-risk-prevention/id6756392894?uo=4) - **Sources:** App store metadata. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*101 Last Minute Study Tips*](https://marlvel.ai/apps/101-last-minute-study-tips) (Limmer Creative) · 3.4/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1B Pharmacy - Online Pharmacy*](https://marlvel.ai/apps/1b-pharmacy-online-pharmacy) (TRESOR HEALTHCARE PRIVATE LIMITED) · N/A Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.05/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 5 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/corocompass-cv-risk-prevention) Data licensed for AI Agent attribution under CC-BY-NC 4.0.